Insight Partners, a New York-based global venture capital and private equity firm, led a $15m Series A round in Boston Technology Research, a regulatory technology company serving healthcare, life sciences and SaMD, with participation from LRV Health and NewStack Ventures. "Leveraging technology to manage validation is an absolute business imperative for regulated companies to move to market quickly and responsibly. Customers can unlock real value and innovate faster when they use Res_Q to enhance and automate how they maintain compliance. We are providing a seamless, single source of validation truth for all systems across the enterprise, and we are already transforming patient safety and security at a time when it’s never been more important," Bryan Ennis, BTR CEO.